International Catalog

ANTI-PHOSPHOLIPIDE ANTIBODIES - ELISA

ETI-Cardiolipin Screen

N0057/96 Wells

Intended use

For the detection of Cardiolipin IgM/IgG Antibodies.

Method

ELISA

Controls included

Two Levels (positive, negative)

Incubations

30 min + 30 min/RT

Chromogen/Substrate

TMB

Feature & benefits

Simple and Objective. Proven Clinical Utility.

Conjugates

HRP

Reading

Spectrophotometric

Sample type

Serum

Sample size

100 µL (1:101)

ETI-Cardiolipin IgG

N0059/96 Wells

Intended use

For the quantitative determination of Cardiolipin IgG Antibodies.

Method

ELISA

Controls included

Two Levels (positive, negative)

Calibrators

4 (0-91 GPL/mL)

Incubations

30 min + 30 min/RT

Chromogen/Substrate

TMB

Feature & benefits

Simple and Objective. Proven Clinical Utility.

Conjugates

HRP

Reading

Spectrophotometric

Sample type

Serum

Sample size

100 µL (1:101)

ETI-Cardiolipin IgM

N0058/96 Wells

Intended use

For the quantitative determination of Cardiolipin IgM Antibodies.

Method

ELISA

Controls included

Two Levels (positive, negative)

Calibrators

4 (0-92 GPL/mL)

Incubations

30 min + 30 min/RT

Chromogen/Substrate

TMB

Feature & benefits

Simple and Objective. Proven Clinical Utility.

Conjugates

HRP

Reading

Spectrophotometric

Sample type

Serum

Sample size

100 µL (1:101)

ETI-Cardiolipin IgA

N0079/96 Wells

Intended use

For the quantitative determination of Cardiolipin IgA Antibodies.

Method

ELISA

Controls included

Two Levels (positive, negative)

Calibrators

4 (0-120 APL/mL)

Incubations

30 min + 30 min/RT

Chromogen/Substrate

TMB

Feature & benefits

Simple and Objective. Proven Clinical Utility.

Conjugates

HRP

Reading

Spectrophotometric

Sample type

Serum

Sample size

100 µL (1:101)

ETI-Beta2 Glycoprotein I IgG

N0056/96 Wells

Intended use

For the quantitative determination of β2 -Glycoprotein I IgG Antibodies.

Method

ELISA

Controls included

Two Levels (positive, negative)

Calibrators

4 (0-100 SG U/mL)

Incubations

30 min + 30 min/RT

Chromogen/Substrate

TMB

Feature & benefits

Simple and Objective. Proven Clinical Utility.

Conjugates

HRP

Reading

Spectrophotometric

Sample type

Serum

Sample size

100 µL (1:101)

ETI-Beta2 Glycoprotein I IgM

N0077/96 Wells

Intended use

For the quantitative determination of β2 -Glycoprotein I IgM Antibodies.

Method

ELISA

Controls included

Two Levels (positive, negative)

Calibrators

4 (0-100 SM U/mL)

Incubations

30 min + 30 min/RT

Chromogen/Substrate

TMB

Feature & benefits

Simple and Objective. Proven Clinical Utility.

Conjugates

HRP

Reading

Spectrophotometric

Sample type

Serum

Sample size

100 µL (1:101)

ETI-Beta2 Glycoprotein I IgA

N0081/96 Wells

Intended use

For the quantitative determination of β2 -Glycoprotein I IgA Antibodies.

Method

ELISA

Controls included

Two Levels (positive, negative)

Calibrators

4 (0-100 SA U/mL)

Incubations

30 min + 30 min/RT

Chromogen/Substrate

TMB

Feature & benefits

Simple and Objective. Proven Clinical Utility.

Conjugates

HRP

Reading

Spectrophotometric

Sample type

Serum

Sample size

100 µL (1:101)